Insights Now

By: PodClips
  • Summary

  • Join the thought leaders at JP Morgan as they engage in a conversational breakdown of big ideas, future trends, emerging topics and their investment implications, complete with key takeaways to help inform building stronger investment plans and portfolios for the long-term.
    © 2024 PodClips
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Asset Allocation in the Year Ahead
    Nov 22 2024
    Season 12 Episode 01 As we usher in a new year, the investment landscape is almost certainly set to change. That’s why in our twelfth season of Insights Now titled, “Preparing for the Path Forward,” Dr. David Kelly will sit down with portfolio managers and strategists from across J.P. Morgan to discuss their key takeaways from 2024, and what they expect from the economy and markets in 2025. To share some of his highest conviction ideas for the year ahead, Dr. David Kelly is joined by Phil Camporeale, Portfolio Manager in our Multi-Asset Solutions group here at J.P. Morgan Asset Management.
    Show More Show Less
    17 mins
  • Alternative Realities: Powering Portfolios with Alternatives
    Nov 21 2024
    Season 01 Episode 07 In this episode, Dr. David Kelly is joined by Ash Williams, Vice Chair of J.P. Morgan Asset Management. Ash served as Chief Investment Officer and Executive Director of the Florida State Board of Administration, where he oversaw $250 billion in assets. He has extensive experience as an institutional investor in both public and private markets. Throughout their conversation, they cover a range of topics surrounding the importance of alternatives in a portfolio and the best approach to constructing a portfolio with alternatives.
    Show More Show Less
    20 mins
  • Alternative Realities: Investing in the Future of Healthcare
    Nov 2 2024
    Season 01 Episode 06 On previous episodes, we’ve discussed the muted return outlook for a traditional 60/40 portfolio and the return-enhancing potential of Private Equity and Venture Capital. As companies wait longer to IPO, investors are turning to private markets for access to the fastest-growing part of a business’s lifecycle. In this episode, we’re going to explore the opportunities in private healthcare and biotechnology. Dr. David Kelly is joined by Gaurav Gupta, Managing Partner of Life Science Private Capital within J.P. Morgan Private Capital. He is a neurosurgeon turned investor, and we’re so excited to have him here to discuss the trends he’s seeing in the market.
    Show More Show Less
    25 mins

What listeners say about Insights Now

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.